Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment